This website uses cookies to improve user experience. By using our website you consent to all cookies in accordance with our Cookie Policy.
Read more
Active substance: Gallium (68Ga) edotreotide
Patient Information / Patienteninformation:
Package Leaflet
Gebrauchsinformation DE
Gebrauchsinformation AT
Marketing authorization in Austria under the brand name Sogacin® / Marktzulassung in Österreich unter dem Markennamen Sogacin®
Additional information for Healthcare Professionals
Marketing Authorization Holder: ITM Medical Isotopes GmbH. A company of the ITM Group.
Please contact our Sales Team, if you need any further information: Email: RadiopharmaOperations(at)itm-radiopharma.com Phone: +49 89 329 8986 6000